CardlyticsCDLX

13F holders, Q2 2026 (June 30)
1holders −60
0new positions
28sold out
$4.49avg. 13F price*

At the end of Q2 2026, 1 institutions reported holding Cardlytics Inc. (CDLX) in their 13F filings, down 60 from Q1 2026. 0 opened new positions and 28 sold out. The largest holder was CAS Investment Partners, LLC ($2.1M).

Company
Cardlytics Inc.
CUSIP
14161W105
Latest filing quarter
Q2 2026

History

Number of 13F holders

050100150 Q1 2024: 144Q1 2024Q2 2024: 127Q2 2024Q3 2024: 111Q3 2024Q4 2024: 107Q4 2024Q1 2025: 108Q1 2025Q2 2025: 89Q2 2025Q3 2025: 81Q3 2025Q4 2025: 70Q4 2025Q1 2026: 61Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions0$0
Exits28$1.3M

All 13F filers, Q1 2026 → Q2 2026: 5,973,502 shares sold, net −5,973,502 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 1 holders

CAS Investment Partners, LLC 0.11% Reduce -90.9% 470,986 $2.1M

"% of holder's portfolio" is CDLX's weight in each manager's 13F, not the share of Cardlytics Inc. the manager owns.